Investigation on the effect of food crop derived food supplements on Acute Respiratory Tract Infections in community dwelling seniors during the winter season

1. Be able to give written informed consent;

2. Be aged ≥65 years;

3. Have a General Practitioner;

4. Be in good physical and mental condition;

1.Are hypersensitive to any of the components of the test product;

2.Have a history (within 5 years) of drug and/or alcohol abuse at the time of enrolment;

3.Are planning extensive travel (maximum of 3 consecutive weeks) over the duration of the study;

4.Have language limitations regarding interviews and questionnaires;

5.Are a resident of a nursing home or on a waiting list for a nursing home;

6.Have a psychiatric disease, gastrointestinal disease (i.e., coeliac disease, Inflammatory Bowel Disease), Rheumatoid arthritis, dementia, cancer, or other diseases deemed significant at the discretion of the study physician;

7.Have a history of significant medical or psychiatric disease, at the discretion of the study physician;

8.Are severely immunocompromised (HIV positive, transplant patient, on antirejection medications, on a steroid treatment for >30 days, or had chemotherapy within the last year);

9. Suffer from an unfavourable physical or mental condition at the discretion of the study physician (i.e. not going to survive the study);

10. Exhibit a deterioration of medical condition or disease, which at the discretion of the study physician, may require withdrawal from the study;

11. Are a NutriLeads or Site employees;

12.Use any other medication at the discretion of the study physician which could impact the overall objectives of the study;

13.Have , or ≤1 year had, a malignant disease (with the exception of basal cell carcinoma) or any concomitant end-stage organ disease; Subjects diagnosed with cancer that significantly reduces life expectancy (i.e. terminal) will be removed from the study, at the discretion of the study physician;

14.Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial;

15. Individual who receive immuno-, radio- or chemo- therapy;

16.Subjects may not be receiving treatment involving experimental drugs. If the subject has been in a recent experimental trial, these latter must have been completed not less than 60 days prior to this study;